Press Release

Friday, 28 January 2022

5-year ESPOIR Trial results and ESPOIR Registry Data to be presented at the DGTHG/DGPK 2022

The 5-year results of the prospective European multi-centre ESPOIR trial will be presented as an on-demand presentation within the 2022 DGTHG/DGPK meeting in Hamburg. The talk will also focus on the available longterm data from the ESPOIR registry including a matched comparison to the two most widely used other options for pulmonary valve replacement.